The economic burden of HER2-targeted therapy among metastatic breast cancer patients

被引：1
|
作者：
Forero-Torres, Andres [1 ]
Anupindi, Vamshi Ruthwik [2 ]
Yeaw, Jason [2 ]
DeKoven, Mitch [2 ]
Feliciano, Joseph [1 ]
Richhariya, Akshara [1 ]
机构：
[1] Seattle Genet, Bothell, WA USA
[2] IQVIA, Falls Church, VA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-18-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-18-17
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.
    Murata, Takeshi
    Takahashi, Maiko
    Hayashida, Tetsu
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [42] The New ASCO/CAP HER2 Guidelines Double the Number of Breast Cancer Patients Eligible for HER2-Targeted Therapy
    Wiktor, A. E.
    Meyer, R. G.
    Shah, M. V.
    Jenkins, R. B.
    CYTOGENETIC AND GENOME RESEARCH, 2014, 142 (03)
  • [43] HER2-targeted therapy in colorectal cancer: a comprehensive review
    Benli, Yeliz
    Arikan, Helin
    Akbulut-caliskan, Ozge
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [44] Dual HER2-targeted approaches in HER2-positive breast cancer
    Ahn, Eugene R.
    Vogel, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 371 - 383
  • [45] HER2-Targeted Therapies in HER2-Low-Expressing Breast Cancer
    Dekker, Tim Johannes Adrianus
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28)
  • [46] Dual HER2-targeted approaches in HER2-positive breast cancer
    Eugene R. Ahn
    Charles L. Vogel
    Breast Cancer Research and Treatment, 2012, 131 : 371 - 383
  • [47] Late cardiotoxicity related to HER2-targeted cancer therapy
    Isabelle Senechal
    Maria Sol Andres
    Jieli Tong
    Ylenia Perone
    Sivatharshini Ramalingam
    Muhummad Sohaib Nazir
    Stuart D Rosen
    Nicholas Turner
    Alistair Ring
    Alexander R Lyon
    Cardio-Oncology, 10
  • [48] Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancer
    Huang, Riqing
    Hu, Anqi
    Rong, Qixiang
    Shu, Ditian
    Chen, Meiting
    Yang, Wei
    Zhang, Yue
    Zheng, Qiufan
    An, Xin
    Xue, Cong
    Li, Haifeng
    Shi, Yanxia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [49] Recent advances in HER2-targeted delivery for cancer therapy
    Dhritlahre, Rakesh Kumar
    Saneja, Ankit
    DRUG DISCOVERY TODAY, 2021, 26 (05) : 1319 - 1329
  • [50] Endocrine therapy plus HER2-targeted therapy, another favorable option for HR+/HER2+advanced breast cancer patients
    Liang, Yuehua
    Liu, Xiaoran
    Yun, Zehui
    Li, Kun
    Li, Huiping
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345